Scarica l'app Stockscreener
4.12
0.24%
-0.010
Dopo l'orario di chiusura:
4.12
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché ADIL Giù?
Forum
Previsione
Frazionamento azionario
Adial Pharmaceuticals Inc Borsa (ADIL) Ultime notizie
Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) - TradingView
A new hire's right to buy 155,446 Adial shares vests over four years. - Stock Titan
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Live Adial Pharmaceuticals, Inc (ADIL) Technical Analysis - Traders Union
Adial Pharmaceuticals, Inc (ADIL) Stock Price History & Data - Traders Union
Adial Pharmaceuticals, Inc Stock Price Today | ADIL Live Chart & News - Traders Union
Adial Pharmaceuticals, Inc Stock Price Prediction: Today, Tomorrow, Next Week (ADIL) - Traders Union
Adial Pharmaceuticals, Inc (ADIL) Earnings Date, Reports and Estimates - Traders Union
Adial Pharmaceuticals, Inc (ADIL) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Adial Pharmaceuticals to replace CEO and CFO after 2026 annual meeting - scanx.trade
Director at Adial Pharma (NASDAQ: ADIL) gets 25,666 stock options - Stock Titan
Adial Shareholders Approve Key Proposals, Meeting Adjourned - TipRanks
Adial Pharmaceuticals Amends Agreements to Restore Nasdaq Compliance - TipRanks
Adial Pharmaceuticals Removes Penalty Provisions in PIPE and Note Exchange to Restore Nasdaq Compliance - TradingView
Why Did Adial Pharmaceuticals (ADIL) Stand Out? - kalkinemedia.com
ADIL Should I Buy - Intellectia AI
Adial Pharmaceuticals Inc Warrant (ADILW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Adial Pharmaceuticals files prospectus for resale of 25.1 million shares - scanx.trade
Lucid Capital initiates coverage on Adial with Buy rating - scanx.trade
Adial PharmaceuticalsProposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling StockholdersSEC Filing - TradingView
Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Moomoo
A new Adial employee gets a 307,814-share option at $5.76 - Stock Titan
Adial (ADIL) Financial Update: Profit Per Share Surpasses Its Benchmark in the Latest Reading; Session Move - vinanet.vn
Adial (ADIL) Shares: Finishes 14.56% Down at $5.31; Current Setup: the Current Price Sits Inside the Supplied Technical Range at the CloseRegression Channel - dars.gov.et
Adial Pharmaceuticals Faces Nasdaq Listing Compliance Challenge - TipRanks
Adial Pharmaceuticals Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Adial (ADIL) Watch: Ends Up by 5.42% at $6.22 in the Latest Reading; Price Context: $5.91 and $6.53 Define the Nearby Reference Levels in the Latest SessionSkew Index - vinanet.vn
Adial (ADIL) Financial Update: EPS Exceeds Its Estimate on the Day; Post-Report Move: Shares Move 9.22% Up at the CloseRevenue Breakdown Analysis - vinanet.vn
Adial Pharmaceuticals (ADIL) Jumps 15% as Trading Volume AcceleratesFade Trade - vinanet.vn
Adial Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Adial Closes $32M Tranche of $64M Financing for Ulcerative Colitis Drug Development - Minichart
Form 8K Adial Pharmaceuticals Inc For: 17 August By Investing.com - Investing.com Nigeria
Weekly Recap: Cash shortfall, warrant reliance and CEO succession, CFO exit - TradingView
Adial Reports $52 Million Second-Quarter Net Loss After Azora Acquisition - Quiver Quantitative
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update - The Manila Times
ADIL Q1 2026 Earnings: EPS Surprise Amid Revenue AbsenceDividend Growth Analysis - vinanet.vn
Adial Pharmaceuticals (ADIL) Slides 9.3% as Biotech Volatility ReturnsSector Leader Stocks - dars.gov.et
Adial Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Adial Pharmaceuticals (NASDAQ: ADIL) lifts cash to $28.7M but flags going‑concern risk - Stock Titan
Form 8K Adial Pharmaceuticals Inc For: 13 August By Investing.com - Investing.com Canada
Adial Pharmaceuticals plans leadership changes tied to annual meeting vote - Investing.com
Adial Pharmaceuticals Plans Major Leadership and Board Transition - TipRanks
ADIL Q1 2026 Earnings: Narrower-than-Expected Loss Delivers 46.85% Positive SurpriseCash Flow Report - Vinanet
Adial Pharmaceuticals Acquires Azora Therapeutics in Stock-and-Preferred Deal - Minichart
Adial Pharmaceuticals announces annual shareholder meeting - Bitget
Form 8K Adial Pharmaceuticals Inc For: 11 August By Investing.com - Investing.com Canada
Adial Pharmaceuticals (NASDAQ: ADIL) outlines Azora merger, heavy dilution and $53M share overhang - Stock Titan
Adial Pharmaceuticals Inc expected to post a loss of $1.03 a shareEarnings Preview - TradingView
Adial Pharmaceuticals (ADIL) Plunges 17% as Shares Test Key $3.78 Support LevelSafe Entry Stocks - careplusvn.com
A. G. P. Initiates Adial Pharmaceuticals(ADIL.US) With Buy Rating, Announces Target Price $11 - Moomoo
Adial Pharmaceuticals Price Target Announced at $11.00/Share by Alliance Global Partners - Moomoo
Adial Pharmaceuticals Initiated at Buy by Alliance Global Partners - Moomoo
CNSY Stock Price and Chart — NASDAQ:CNSY - tradingview.com
ADIL Q1 2026 Earnings: EPS Beats Estimates Sharply, But Revenue Remains AbsentEarnings Revision Downgrade - careplusvn.com
0.05%
0.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):